Amanote Research

Amanote Research

    RegisterSign In

FDA to Review Risks of Antidepressants in Adults

BMJ
doi 10.1136/bmj.329.7470.816-b
Full Text
Open PDF
Abstract

Available in full text

Date

October 9, 2004

Authors
J. Lenzer
Publisher

BMJ


Related search

Risks of Tricyclic Antidepressants

British Journal of Psychiatry
MedicinePsychiatryMental Health
1978English

FDA Urges "Black Box" Warning on Pediatric Antidepressants

CMAJ
Medicine
2004English

Antidepressants and the Risks of Untreated Illnesses

Psychiatric Bulletin
2000English

Antidepressants for Minors: Benefits, Risks and Peter Gøtzsche

Bipolar Disorders
PsychiatryBiological PsychiatryMental Health
2019English

FDA Bars Own Expert From Evaluating Risks of Painkillers

BMJ
2004English

Drug Suicide Risks Prompt Call for FDA Action

Nature
Multidisciplinary
2004English

Antidepressants and Suicide Risk: How Did Specific Information in FDA Safety Warnings Affect Treatment Patterns?

Psychiatric Services
MedicinePsychiatryMental Health
2010English

Risks of Statin Therapy in Older Adults

JAMA Internal Medicine
Internal Medicine
2017English

Risks of Intracranial Haematoma in Head Injured Adults

BMJ
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy